Estimate the Levels of Copeptin and Chromogranin A and Some Biochemical Parameters in Patients with Chronic Diseases
The current study aimed to estimate the concentrations of copeptin and chromogranin A and some biochemical parameters in patients with chronic diseases. Eighty-five subjects reported different chronic diseases in Azadi Teaching Hospital and Al-Jumhuri Hospital from September 2023 to January 2024. E...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tikrit University
2025-02-01
|
| Series: | Tikrit Journal of Pure Science |
| Subjects: | |
| Online Access: | https://tjpsj.org/index.php/tjps/article/view/1634 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The current study aimed to estimate the concentrations of copeptin and chromogranin A and some biochemical parameters in patients with chronic diseases. Eighty-five subjects reported different chronic diseases in Azadi Teaching Hospital and Al-Jumhuri Hospital from September 2023 to January 2024. Experimental work was carried out at the Laboratories of Al-Jumhuri Hospital in Kirkuk, Iraq. The volunteers in the current study were divided as follows: 30 healthy volunteers as a control group. 25 patients with chronic kidney disease. 30 patients with diabetes mellitus. 30 patients with heart failure diseases. The results showed some kidney functions in chronic kidney disease (CKD), diabetes mellitus (DM), and heart failure (HF) patients, where urea and creatinine levels in chronic kidney disease (CKD) patients significantly increased (P ≤ 0.05) compared to the control group. In DM patients and HF patients, the urea and creatinine levels showed non-significant (P > 0.05) change compared to the control group. CRP percentage in CKD patients was (52.0 %). DM patients and HF patients were (50.0 %) and (46.7 %), respectively, compared to the control group, which was (0.0 %). On the other hand, the results showed copeptin levels in CKD, DM, and heart failure patients were significantly (P ≤ 0.05) elevated compared to the control group. Chromogranin A (CgA) levels in CKD, DM, and heart failure patients significantly increased (P ≤ 0.05) compared to the control group. Based on the results of the current study, both copeptin and chromogranin A can be considered an important indicator in the diagnosis of some chronic diseases.
|
|---|---|
| ISSN: | 1813-1662 2415-1726 |